• PDF: Delivered by email within 12 to 24 hours of placing the order (Mon-Fri)
  • PRINT/CD-ROM: Despatched within 2 to 4 working days.

Global Vaccine Market Forecast to 2013

  • Publication Date:November 2011
  • Publisher:RNCOS
  • Product Type: Report
  • Pages:140

Global Vaccine Market Forecast to 2013

Vaccine represents one of the most attractive and fast growing sectors, with players' revenue exceeding their expectations. The global vaccine market is primarily divided into adult and pediatric segments, further classified into several other sub-segments. Both the adult and pediatric vaccine sectors have sustained the growth momentum and industry participants have been devising strategies to enlarge their presence in these segments.

According to our new research report, "Global Vaccine Market Forecast to 2013", the global vaccine market is likely to reach an amount worth to US$ 27.6 Billion by the end of 2011, on the back of key factors, such as high growth in emerging markets, technological advancements, strong support from government, and other active associations like WHO and GAVI and increased investment in research activities. With the successful launch of new vaccines in the coming years for key indications, the market for vaccines may further exhibit good performance and it is estimated that the market will reach to the mark of US$ 33 Billion by 2013.

Our analysis of the global vaccine market illustrates that a large number of players are spending huge amount on the aspect of research and development. This is mainly due to the fact that the successful launch of very first vaccine products for any virus may significantly impact the market share. Currently, the companies are actively participating in the trials of vaccines for cancer, malaria, tuberculosis, HIV/AIDS, among others.

The report "Global Vaccine Market Forecast to 2013", provides an in-depth analysis of the global vaccine market by focusing on key countries of the world. It investigates the current market trends and analyzes their impact on the overall market performance in a broad way. Moreover, the report identifies all the necessary factors and aspects related to market and represent current industry status with future forecast on vaccine types and countries for 2010-2013. In addition, the description of key players and their recent activities have been provided to showcase an effective and balanced outlook of the global vaccine market.

  • 1. Analyst View
  • 2. Research Methodology
  • 3. Market Overview
  • 4. Key Market Drivers
    • 4.1 Improved Routine Immunization
    • 4.2 Emerging Markets
    • 4.3 Technological Developments
    • 4.4 Investment in Vaccine Research
  • 5. Emerging Trends
    • 5.1 DNA Vaccines: Gaining Popularity
    • 5.2 M&As in Vaccine Market
    • 5.3 Vaccine Delivery Advancements
  • 6. Pediatric Vaccines
    • 6.1 Pneumococcal
    • 6.2 Polio
    • 6.3 Varicella
    • 6.4 Meningococcal
    • 6.5 Rotavirus
    • 6.6 DTP
    • 6.7 Measles, Mumps & Rubella (MMR)
    • 6.8 Tuberculosis
  • 7. Adult/Travel & Therapeutic Vaccines
    • 7.1 Hepatitis B
    • 7.2 Malaria
    • 7.3 Yellow Fever
    • 7.4 Rabies
    • 7.5 Japanese Encephalitis
    • 7.6 Typhoid
    • 7.7 West Nile
    • 7.8 HIV
    • 7.9 Cancer
    • 7.10 Influenza
  • 8. Key Geographical Markets
    • 8.1 US
    • 8.1.1 Market Overview
    • 8.1.2 Key Players
    • 8.1.3 Product Portfolio
    • 8.2 Europe
    • 8.2.1 Market Overview
    • 8.2.2 Key Players
    • 8.2.3 Product Portfolio
    • 8.3 China
    • 8.3.1 Market Overview
    • 8.3.2 Key Players
    • 8.3.3 Product Portfolio
    • 8.4 India
    • 8.4.1 Market Overview
    • 8.4.2 Key Players
    • 8.4.3 Product Portfolio
    • 8.5 Japan
    • 8.5.1 Market Overview
    • 8.5.2 Key Players
    • 8.5.3 Product Portfolio
    • 8.6 Brazil
    • 8.6.1 Market Overview
    • 8.6.2 Key Players
    • 8.6.3 Product Portfolio
  • 9. Restraints in Vaccine Industry
    • 9.1 High R&D Cost
    • 9.2 Lack of Infrastructure for Trials and Manufacturing
    • 9.3 Vaccine Supply
    • 9.4 Ineffective Distribution
  • 10. Competitive Landscape
    • 10.1 Sanofi-Aventis
    • 10.2 Novartis
    • 10.3 GSK
    • 10.4 Pfizer
    • 10.5 Merck & Co.
  • List of Figures:
    • Figure 3-1: Global - Vaccine Market (Billion US$), 2010-2013
    • Figure 4-1: Global - Vaccine R&D Investment by Region (%), 2010
    • Figure 5-1: Global - Key M&As in Vaccine Market (2005-2010)
    • Figure 6-1: Global - Causes of Deaths in Children (less than 5 Years) among Low-income Countries (%), 2011
    • Figure 6-2: Global - Pneumococcal Vaccine Market (Billion US$), 2010-2013
    • Figure 6-3: Global - Number of Polio Incidences (2007-2010)
    • Figure 6-4: Global - Polio Vaccine Market (Billion US$), 2010-2013
    • Figure 6-5: Global - Varicella Vaccine Market (Billion US$), 2010-2013
    • Figure 6-6: Global - Meningococcal Vaccine Market (Million US$), 2010-2013
    • Figure 6-7: Global - Rotavirus Vaccine Market (Million US$), 2010-2013
    • Figure 6-8: Global - Rotavirus Vaccine Market by Region (%), 2010
    • Figure 6-9: Global - Number of Diphtheria Incidences by Region (2009 & 2010)
    • Figure 6-10: Global - Number of Ntetanus Incidences by Region (2009 & 2010)
    • Figure 6-11: Global - Number of Ttetanus Incidences by Region (2009 & 2010)
    • Figure 6-12: Global - Number of Pertussis Incidences by Region (2009 & 2010)
    • Figure 6-13: Global - Number of Measles Incidences by Region (2009 & 2010)
    • Figure 6-14: Global - Number of Mumps Incidences by Region ('000), 2009 & 2010
    • Figure 6-15: Global - Number of Rubella Incidences by Region (2009 & 2010)
    • Figure 6-16: Global - Number of Tuberculosis Incidences by Region (2008 & 2009)
    • Figure 7-1: Global - Hepatitis B Surface Antigen Prevalence (%)
    • Figure 7-2: Global - Hepatitis B Vaccine Market (Billion US$), 2010-2013
    • Figure 7-3: Global - Malaria Vaccines under Pipeline
    • Figure 7-4: Global - Yellow Fever Vaccine Market (Million US$), 2010 & 2013
    • Figure 7-5: Global - Japanese Encephalitis Market (Million US$), 2010-2013
    • Figure 7-6: Global - R&D Investment in AIDS Vaccine Development (Million US$), 2006-2009
    • Figure 7-7: Global - Sources for Funding in HIV Vaccine R&D (%), 2009
    • Figure 7-8: Global - Cancer Vaccine Market (Billion US$), 2010-2013
    • Figure 7-9: Global - Seasonal Influenza Vaccine Market (Billion US$), 2010-2013
    • Figure 8-1: Global - Vaccine Market by Region (%), 2010
    • Figure 8-2: Global - Forecast for Vaccine Market by Region (%), 2013
    • Figure 8-3: US - Vaccine Market (Billion US$), 2010-2013
    • Figure 8-4: US - Share of Key Players in Vaccine Market (2010)
    • Figure 8-5: US - Pediatric Vaccine Market (Billion US$), 2010-2013
    • Figure 8-6: US - Adult Vaccine Market (Billion US$), 2010-2013
    • Figure 8-7: US - Hepatitis Vaccine Market (Billion US$), 2010-2013
    • Figure 8-8: US - Share of Key Players in Seasonal Influenza Vaccine Production (2010-2011)
    • Figure 8-9: US - Seasonal Influenza Vaccine Production and Consumption (Million Doses), 2006-07 to 2010-11
    • Figure 8-10: US - Seasonal Influenza Vaccine Market (Billion US$), 2010-2013
    • Figure 8-11: Europe - Vaccine Market (Billion US$), 2010-2013
    • Figure 8-12: Europe - Share of Key Players in Vaccine Market (2008)
    • Figure 8-13: China - Vaccine Market (Billion RMB), 2010-2013
    • Figure 8-14: China - Share of Key Players in Vaccine Market (2008)
    • Figure 8-15: China - Influenza Vaccine Market (Million US$), 2010-2013
    • Figure 8-16: India - Share of Domestic Consumption and Exports in Vaccine Market (2010)
    • Figure 8-17: India - Vaccine Market (Million US$), 2010-2013
    • Figure 8-18: India - Share of Key Players in Vaccine Market (2010)
    • Figure 8-19: Japan - Vaccine Market (Billion US$), 2010-2013
    • Figure 8-20: Japan - Seasonal Influenza Vaccine Market (Million US$), 2010-2013
    • Figure 8-21: Japan - Share of Domestic and Foreign Players in Vaccine Market (2009)
    • Figure 8-22: Brazil - Vaccine Market (Billion BRL), 2010-2013
    • Figure 8-23: Brazil - Share of Public and Private Sector in Vaccine Market
    • Figure 8-24: Brazil - Share of Key Players in Private Sector Vaccine Market (2008)
    • Figure 9-1: Global - Dose Consumption and Revenue by Regional Income (%)
    • Figure 10-1: Global - Share of Key Players in Vaccine Market (2009)
  • List of Tables:
    • Table 3-1: Global - Production Method for Key Vaccines
    • Table 4-1: Global - Key Health Indicators by Income Classification
    • Table 5-1: Global - Recent Deals between Key Western Vaccine Manufacturers and Companies in Emerging Markets
    • Table 5-2: Global - Key Intradermal Delivery Devices
    • Table 6-1: Global - Leading DTP Vaccine Brands (Million US$), 2008
    • Table 6-2: Global - Leading MMR Vaccine Brands (Million US$), 2008
    • Table 6-3: Global - Tuberculosis Vaccines under Pipeline (2010)
    • Table 7-1: Global - Number of HIV/AIDS Patients by Region (2009)
    • Table 7-2: Global - HIV Vaccines under Pipeline
    • Table 7-3: Global - Cancer Statistics in More Developed and Less Developed Regions (2008)
    • Table 7-4: Global - Cancer Vaccines under Pipeline (2009)
    • Table 7-5: Global - Top 5 Companies' Pandemic Influenza (H1N1) Vaccine Sales (Million US$), 2009
    • Table 8-1: China - Number of Reported Cases of Diseases Preventable by Vaccine (2008 & 2009)
    • Table 8-2: China - Vaccine Classification
    • Table 8-3: China - Annual Pediatric Vaccine Doses Requirement (Million Doses)
    • Table 8-4: Japan - Sales of Top Domestic Vaccine Manufacturers (Million JPY)
    • Table 9-1: Health Statistics in Developed and Developing Countries (%)
    • Table 10-1: Sanofi Aventis - Strengths and Weaknesses
    • Table 10-2: Novartis - Strengths and Weaknesses
    • Table 10-3: GSK - Strengths and Weaknesses
    • Table 10-4: Pfizer - Strengths and Weaknesses
+44 20 8816 8548

Ask a question about Global Vaccine Market Forecast to 2013

Enter the characters you see in the picture below
Captcha